On December 16, under the guidance of Shanghai Municipal Commission of Commerce, China Chamber of Commerce for Import and Export of Medicines and Health Products, and China Medicinal Biotech Association, Yangtze River Delta Biomedical Industry Service Development Alliance was officially launched in Shanghai, sponsored by Shanghai Biopharmaceutics Industry Association and supported by Zhejiang Pharmaceutical Association, Anhui Pharmaceutical Profession Association, and Jiangsu Society of Biochemistry and Molecular Biology. Jack Yang, Director of Building and Facilities, Greater China, Bureau Veritas, was invited to attend the launching ceremony of Yangtze River Delta Biomedical Industry Service Development Alliance and granted the award of member enterprise plate on behalf of BV.
Before Ji Junqiu, President of Anhui Pharmaceutical Profession Association, read out the alliance proposal, Sun Jiarong, Secondary Inspector of Shanghai Municipal Commission of Commerce, Wang Maochun, VP of China Chamber of Commerce for Import and Export of Medicines and Health Products, Wu Chaohui, Executive President of China Medicinal Biotech Association, and Wu Qiang, Deputy District Head of Pudong New Area, delivered congratulatory speeches respectively. After that, Xu Xingfeng, Deputy Commissioner of Special Commissioner's Office of the Ministry of Commerce in Shanghai, and Fu Daxu, President of Shanghai Biopharmaceutics Industry Association, jointly unveiled the establishment of the Alliance.
In order to thoroughly implement the spirit of the important speech of General Secretary Xi Jinping on promoting the integrated development of the Yangtze River Delta, and earnestly serve the integrated development strategy of the Yangtze River Delta and promote the high quality development of the biopharmaceutics industry in the Yangtze River Delta region as early as this year, BV has signed a strategic cooperation framework agreement with Shanghai Biopharmaceutics Industry Association and participated as one of the first batch enterprises in the initiation of New Infrastructure and Refined Urban Management Industry Alliance of the Yangtze River Delta Region.
In response to the national strategic development guidelines, BV is committed to achieving multi-directional and multi-dimensional cooperation, better promoting the biomedical investment and implementation in the Yangtze River Delta, facilitating the industrial and internal planning of the park, so as to serve as the assistant of the government to cultivate industries and accelerate the overall industrial planning and regional subdivision planning of the Yangtze River Delta Region, give full play to agglomeration efforts, regional connectivity and policy synergy efficiency of the Yangtze River Delta biomedical industry. Besides, BV strives to promote the high-quality development of the Yangtze River Delta biomedical industry, to build the biomedical industry an influential industrial highland in the world.
“After the integration of the Yangtze River Delta is positioned as a national strategy, the coordinated development of Jiangsu, Anhui, Zhejiang Province and Shanghai City is of particular importance. The biopharmaceutical industry serves as a key industry in the Yangtze River Delta Region, carrying a critical historical mission. Bureau Veritas, as the only international consulting organization for this alliance jointly initiated by the provincial biomedical associations in the four places, fully demonstrates its commitment to boldly undertaking corporate responsibilities as a multinational enterprise," said Jack Yang, Director of Building and Facilities, Greater China, Bureau Veritas, when he receiving the awarded plate from Yangtze River Delta Biomedical Industry Service Development Alliance on behalf of BV.